.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Jennifer Makalowski

Cologne, DE

IOZK

Vortrag

27.09.2023
Poster
P01
Individualized multimodal immunotherapy for cervical cancer: Single institution experience in a case series
Clinical Applications & Trials

Weitere Beteiligungen

27.09.2023
Poster
P01
Individualized multimodal immunotherapy for cervical cancer: Single institution experience in a case series
Clinical Applications & Trials
29.09.2023
15:42 – 15:54 10 Min. 2 Min.
Multiphase combined treatment for adults with GBM, including individualized multimodal immunotherapy: Single institute real world medical data in the light of clinical trial research data
Clinical Applications & Trials